DE · NYSE
| FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $45.68B | $51.72B | $61.25B | $52.58B | $44.02B | $35.54B | $39.26B | $37.36B |
| Research & Development | $2.31B | $2.29B | $2.18B | $1.91B | $1.59B | $1.64B | $1.78B | $1.66B |
| Selling, General & Administrative | $4.66B | $4.84B | $4.59B | $3.86B | $3.38B | $3.48B | $3.55B | $3.46B |
| Operating Expenses | $39.43B | $42.51B | $48.23B | $43.45B | $36.42B | $31.66B | $35.17B | $33.29B |
| Operating Income | — | $9.04B | $12.96B | $9.51B | $8.01B | $4.30B | $4.42B | $4.48B |
| Interest Expense | $3.17B | $3.35B | $2.45B | $1.06B | $993.00M | $1.25B | $1.47B | $1.20B |
| Income Before Taxes | $6.26B | $9.21B | $13.02B | $9.13B | $7.60B | $3.88B | $4.09B | $4.07B |
| Provision for Income Taxes | $1.26B | $2.09B | $2.87B | $2.01B | $1.66B | $1.08B | $852.00M | $1.73B |
| Net Income | $5.03B | $7.10B | $10.17B | $7.13B | $5.96B | $2.75B | $3.25B | $2.37B |
| Basic EPS | $18.55 | $25.73 | $34.80 | $23.42 | $19.14 | $8.77 | $10.28 | $7.34 |
| Diluted EPS | $18.50 | $25.62 | $34.63 | $23.28 | $18.99 | $8.69 | $10.15 | $7.24 |
| Basic Shares Outstanding | 270.90M | 276.00M | 292.20M | 304.50M | 311.60M | 313.50M | 316.50M | 322.60M |
| Diluted Shares Outstanding | 271.70M | 277.10M | 293.60M | 306.30M | 314.00M | 316.60M | 320.60M | 327.30M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Oct 2026 | $18.26 | $17.60 | $18.83 | 11 | ↑3 ↓1 |
| Oct 2027 | $22.90 | $20.80 | $23.98 | 11 | ↑2 ↓4 |
| Oct 2028 | $27.88 | $26.75 | $29.71 | 5 | ↑2 ↓0 |
